<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04885569</url>
  </required_header>
  <id_info>
    <org_study_id>PILL-CAMIAB-001</org_study_id>
    <nct_id>NCT04885569</nct_id>
  </id_info>
  <brief_title>Culturally Adapted CBT Based Motivational Interviewing and Mindfulness Intervention for Substance Use Disorder in Pakistan (CAMIAB)</brief_title>
  <official_title>Feasibility Study of Culturally Adapted Cognitive Behavioral Therapy Based Integrated Motivational Interviewing and Mindfulness Intervention for Substance Use Disorder in Pakistan (CAMIAB)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pakistan Institute of Living and Learning</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pakistan Institute of Living and Learning</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study has both quantitative and qualitative components. The aim of study is to:&#xD;
&#xD;
        1. Culturally adapt and integrate the existing Cognitive Behavioral Therapy based&#xD;
           Motivational Interviewing (MICBT) and Mindfulness based relapse prevention intervention&#xD;
           (MBRP) intervention for people with substance use disorder in Pakistan&#xD;
&#xD;
        2. Test the feasibility and acceptability of the integrated intervention called CAMIAB&#xD;
           ('CAMIAB' means success in Urdu) in a randomized control trial (RCT).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evidence based psychological interventions are effective treatment for Substance Use&#xD;
      Disorders but there is little evidence on effectiveness of these interventions in LMICs such&#xD;
      as Pakistan. This study aims to culturally adapt the existing CBT based Motivational&#xD;
      Interviewing (MICBT) intervention and integrate this with Mindfulness-Based Relapse&#xD;
      Prevention (MBRP) intervention for people with SUD and to test the feasibility, and&#xD;
      acceptability of the intervention in a randomized control trial (RCT) comparing four groups:&#xD;
      1) CBT based motivational interviewing group, 2) mindfulness based relapse prevention&#xD;
      intervention group, 3) the integrated CBT based motivational interviewing integrated with&#xD;
      Mindfulness based relapse prevention group (CAMIAB) and 4) treatment as usual group (TAU).&#xD;
      The treatment as usual for all treatment arms will continue. For cultural adaptation of&#xD;
      intervention, focus groups will be conducted with key stakeholders including male and female&#xD;
      substance use disorder (SUD) service users and those in recovery, family members of the&#xD;
      people with SUD, health professionals working with people with SUD, community leaders,&#xD;
      religious scholars (such as Imams) and representatives of the community&#xD;
      mosques/Temples/Church. Individual interviews will be offered to participants who prefer this&#xD;
      over a focus group.&#xD;
&#xD;
      After cultural adaptation of intervention, this will be tested on a small group of&#xD;
      participants N=12, which will allow us to preliminarily test the intervention.&#xD;
      Semi-structured, one on one interviews will be undertaken with the participants in the test&#xD;
      run. This will help to obtain their opinions on the intervention, its relevance and&#xD;
      acceptability and further adaptations in the intervention will be made if needed.&#xD;
&#xD;
      A total of 260 participants with SUD (n=65) in each of the four groups) will participate in a&#xD;
      feasibility randomized control trial. Participants will be recruited from primary care&#xD;
      hospitals and drug rehabilitation centers in Karachi, Lahore, Rawalpindi, Hyderabad, and&#xD;
      Peshawar Pakistan. Intervention will take place weekly over a period of 12 weeks. The&#xD;
      intervention will consist of individual as well as group sessions. Assessments will be&#xD;
      completed at baseline, after completion of intervention (12th week) and 24th week post&#xD;
      randomization. All assessments will be administered by masked research assistants (RAs), not&#xD;
      involved in delivering intervention sessions. The therapists delivering the intervention will&#xD;
      be trained and will be provided ongoing supervisions by a senior therapist.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2021</start_date>
  <completion_date type="Anticipated">June 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility measures</measure>
    <time_frame>From baseline to 3rd month (at the end of intervention)</time_frame>
    <description>Feasibility will be determined by recruitment rates and retention rates. The criterion for success of feasibility is to recruit &gt;50% of eligible participants and retention rate of 70%.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acceptability measure</measure>
    <time_frame>From baseline to 3rd month (at the end of intervention)</time_frame>
    <description>Acceptability will be determined based on the number of sessions attended by participants and success criterion for intervention acceptability is mean attendance rate of at least 8 sessions.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Maudsley Addiction Profile</measure>
    <time_frame>Change in problem scores from Baseline to 3rd Month and 6th month</time_frame>
    <description>The Maudsley Addiction Profile is a brief, questionnaire that measures problems in four domains: substance use, health risk behaviour, physical and psychological health, and personal/social functions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Short Warwick-Edinburgh Mental Well-being Scale</measure>
    <time_frame>Change in scores from baseline to 3rd Month and 6th month</time_frame>
    <description>The Short Warwick-Edinburgh Mental Well-being Scale is a 7 items measure that will be used to measure mental wellbeing. It consists of 7 statements on a 5 point Likert scale. The minimum scale score is 7 and the maximum is 35. The high score indicates high mental wellbeing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EuroQol-5</measure>
    <time_frame>Change in scores from baseline to 3rd Month and 6th month</time_frame>
    <description>Quality of life will be measured using EuroQoL (EQ-5D) scale. This is a standardized instrument to measure health status and associated population utility weights. It measures five dimensions of health (mobility, self-care, usual activities, pain/ discomfort and anxiety/ depression) at different levels that include &quot;no problems, slight problems, moderate problems, severe problems, and unable to do/extreme&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Client service receipt inventory</measure>
    <time_frame>Changes from baseline to 3rd Month and 6th month</time_frame>
    <description>CSRI will be used to estimate the health and social services received.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">260</enrollment>
  <condition>Substance Use Disorder (SUD)</condition>
  <arm_group>
    <arm_group_label>CBT based Motivational Interviewing Group (MICBT)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm will receive a total of 12 weekly sessions of CBT based Motivational Interviewing over a period of 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mindfulness based Relapse Prevention Group (MBRP)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm will receive a total of 12 weekly sessions of mindfulness intervention over a period of 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Integrated MICBT and MBRP Group (CAMIAB)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This will be integrated MICBT plus MBRP intervention. Participants will receive a total of 12 weekly sessions of this integrated CAMIAB intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment as usual (TAU)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This will be routine care psychological treatment that they will be receiving.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CBT based Motivational interviewing (MICBT)</intervention_name>
    <description>The culturally adapted MICBT will include approaches of motivational interviewing. Motivational interviewing (MI) is a well-developed and researched tool, for exploring and resolving the ambivalence to change substance use behaviour. While MI is seen as an acceptable and effective intervention to increase and consolidate motivation, to make positive changes in individuals with problematic substance use. The intervention recognises that ambivalence to change substance use behaviour is common and deals with it in the early stages of therapy using MI techniques. The intervention also recognises the need to identify and address obstacles in changing drug taking behaviour and offers ways of managing these difficulties from a cognitive behavioural formulation.</description>
    <arm_group_label>CBT based Motivational Interviewing Group (MICBT)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness based Relapse Prevention (MBRP)</intervention_name>
    <description>MBRP has been designed as a manualized outpatient aftercare program that incorporates cognitive-behavioural skills (i.e., effective coping skills, self-efficacy, and recognizing common antecedents of relapse) with mindfulness-based practices to decrease the probability of relapse by increasing awareness and flexible responding in the presence of substance use triggers. Exercises and practices of intervention are designed to explore the functions of habitual reactive behaviour such as substance use focusing the balance and relationship between acceptance of present moment and skilful action that makes real changes.</description>
    <arm_group_label>Mindfulness based Relapse Prevention Group (MBRP)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Integrated MICBT and MBRP (CAMIAB)</intervention_name>
    <description>This will be integrated CBT based motivational interviewing plus mindfulness based relapse prevention intervention group.</description>
    <arm_group_label>Integrated MICBT and MBRP Group (CAMIAB)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
          -  Participants with substance use disorder&#xD;
&#xD;
          -  Meeting DSM-V criteria for substance use disorder&#xD;
&#xD;
          -  Age 18 years and above&#xD;
&#xD;
          -  Being able to understand spoken or written Urdu&#xD;
&#xD;
          -  Have undergone through the process of detoxification before study intervention&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
        â€¢ Any evidence of organic brain disease, clinically significant cooccurring medical illness&#xD;
        or mental illness to the extent that can impede their ability to provide informed consent&#xD;
        or engagement in the intervention.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Imran Bashir Chaudhry, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pakistan Institute of Living and Learning</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Imran Bashir Chaudhry, Prof.</last_name>
    <phone>02135871845</phone>
    <email>imran.chaudhry@pill.org.pk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Muqaddas Asif, Ms.</last_name>
    <phone>04235775483</phone>
    <email>muqaddas.asif@pill.org.pk</email>
  </overall_contact_backup>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>April 25, 2021</study_first_submitted>
  <study_first_submitted_qc>May 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 13, 2021</study_first_posted>
  <last_update_submitted>July 17, 2021</last_update_submitted>
  <last_update_submitted_qc>July 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

